KEY ADVERSE EVENTS AFTER CHILDHOOD CANCER

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是观察儿童癌症治疗对象中晚发并发症的发生情况；研究晚发并发症与癌症类型、癌症分期和治疗的关系；并比较有晚发并发症的癌症患者(S)和诊断和治疗相同的癌症患者中没有晚发并发症的患者(S)；了解某些个人、癌症治疗(S)或基因(从父母传给孩子的特征的物理单位)是否与晚发并发症的风险增加有关(S)。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goals of this study are to look at how late-occurring complications develop among subjects going through treatment for childhood cancer; to study how late-occurring complications relate to type of cancer, stage of cancer and treatment; and to compare subjects with cancer who have a late-occurring complication(s) to subjects with cancer with the same diagnosis and treatment who do not have late-occurring complication(s); to see if certain individuals, cancer treatment(s), or genes (the physical unit that carries characteristics from parent to child) are related to an increased risk of late occurring complication(s).